Caxton Associates »

BioCryst Pharmaceuticals shares owned by Caxton Associates

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Caxton Associates from 13F filings

Historical chart of Caxton Associates investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Caxton Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Caxton Associates

Quarter filed Position value Share count Share price at filing
2025-12-31 $298k 38k 7.80
2025-09-30 $119k 16k 7.59
2025-06-30 $254k 28k 8.96
2025-03-31 $315k 42k 7.50